Share Price and Basic Stock Data
Last Updated: February 14, 2026, 9:08 pm
| PEG Ratio | 2.27 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Narayana Hrudayalaya Ltd operates within the Hospitals & Medical Services sector and reported a current price of ₹1,865 with a market capitalization of ₹38,086 Cr. The company’s revenue trajectory has shown significant growth, with total sales increasing from ₹3,701 Cr in March 2022 to ₹4,525 Cr in March 2023. The trailing twelve months (TTM) revenue stood at ₹5,961 Cr, indicating a robust upward trend. Quarterly sales figures illustrate this momentum, with sales rising from ₹1,142 Cr in September 2022 to ₹1,305 Cr by September 2023. The growth in sales is complemented by a consistent increase in operating profit margins (OPM), which reached 24% in the most recent reporting period. The company’s ability to maintain such revenue growth in a competitive environment reflects its strong market positioning and operational efficiency.
Profitability and Efficiency Metrics
The profitability metrics for Narayana Hrudayalaya Ltd demonstrate a healthy financial performance. For the fiscal year ending March 2025, the net profit was reported at ₹791 Cr, translating to an earnings per share (EPS) of ₹38.66. The return on equity (ROE) stood at 24.2%, while return on capital employed (ROCE) was recorded at 20.8%, both of which are commendable compared to typical sector averages. The operating profit margin (OPM) has consistently remained around 24%, showcasing effective cost management. The interest coverage ratio (ICR) at 9.35x suggests that the company comfortably meets its interest obligations, further underscoring its operational efficiency. However, the increase in interest expenses, which rose to ₹163 Cr in March 2025, could pressure future profitability if not managed effectively.
Balance Sheet Strength and Financial Ratios
Narayana Hrudayalaya Ltd’s balance sheet reflects a solid financial structure, with total assets amounting to ₹7,271 Cr as of March 2025. The company’s reserves have significantly increased to ₹3,855 Cr, indicating strong retained earnings and financial stability. With borrowings reported at ₹2,340 Cr, the total debt-to-equity ratio stood at 0.61, which is moderate and suggests prudent leverage. The current ratio of 2.14 and quick ratio of 2.04 highlight the company’s strong liquidity position, enabling it to meet short-term liabilities comfortably. The price-to-book value (P/BV) ratio at 9.54x indicates that the stock is trading at a premium compared to its book value, which may reflect investor confidence but could also imply a potential overvaluation relative to the sector.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Narayana Hrudayalaya Ltd indicates a stable investor base, with promoters holding 63.85% of the shares. Foreign Institutional Investors (FIIs) accounted for 10.49%, while Domestic Institutional Investors (DIIs) held 7.76%. The public shareholding has shown a gradual increase, rising to 17.29% as of September 2025, reflecting growing retail investor interest. The number of shareholders has also increased significantly, standing at 2,26,480, which indicates rising confidence in the company’s future prospects. However, the decline in FII and DII holdings in recent quarters could raise concerns about potential shifts in investor sentiment. Continuous monitoring of this trend is essential for assessing overall market confidence in the company.
Outlook, Risks, and Final Insight
The outlook for Narayana Hrudayalaya Ltd remains positive, bolstered by strong revenue growth and robust profitability metrics. However, potential risks include rising interest expenses that could impact net profits and a high P/BV ratio that raises concerns about valuation. Furthermore, the healthcare sector is subject to regulatory changes that could affect operational costs and profitability. As the company continues to expand its services and capacity, maintaining operational efficiency will be critical. If Narayana Hrudayalaya can navigate these challenges effectively while capitalizing on its growth opportunities, it may enhance shareholder value. Conversely, failure to manage debt levels and costs could hinder its ability to sustain profitability in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dr Lalchandani Labs Ltd | 14.5 Cr. | 16.7 | 21.2/7.24 | 30.8 | 11.7 | 0.00 % | 2.81 % | 3.08 % | 10.0 |
| Asarfi Hospital Ltd | 335 Cr. | 170 | 221/72.9 | 20.0 | 45.2 | 0.00 % | 15.8 % | 14.1 % | 10.0 |
| Narayana Hrudayalaya Ltd | 37,190 Cr. | 1,820 | 2,372/1,296 | 45.0 | 199 | 0.25 % | 20.8 % | 24.2 % | 10.0 |
| Lotus Eye Hospital & Institute Ltd | 235 Cr. | 113 | 148/55.0 | 362 | 29.2 | 0.00 % | 2.99 % | 1.22 % | 10.0 |
| Industry Average | 12,586.67 Cr | 529.93 | 114.45 | 71.28 | 0.06% | 10.60% | 10.65% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,142 | 1,128 | 1,222 | 1,233 | 1,305 | 1,204 | 1,246 | 1,306 | 1,367 | 1,335 | 1,475 | 1,507 | 1,644 |
| Expenses | 898 | 874 | 946 | 963 | 997 | 925 | 955 | 1,004 | 1,058 | 1,027 | 1,118 | 1,171 | 1,243 |
| Operating Profit | 244 | 254 | 276 | 271 | 308 | 279 | 291 | 302 | 309 | 307 | 358 | 337 | 401 |
| OPM % | 21% | 23% | 23% | 22% | 24% | 23% | 23% | 23% | 23% | 23% | 24% | 22% | 24% |
| Other Income | 31 | 12 | 15 | 15 | 18 | 18 | 26 | 24 | 23 | 18 | 20 | 24 | 24 |
| Interest | 15 | 19 | 21 | 21 | 23 | 25 | 28 | 34 | 35 | 37 | 41 | 45 | 42 |
| Depreciation | 49 | 57 | 56 | 59 | 55 | 63 | 65 | 61 | 65 | 70 | 82 | 84 | 87 |
| Profit before tax | 211 | 190 | 214 | 206 | 248 | 209 | 225 | 231 | 232 | 219 | 254 | 232 | 296 |
| Tax % | 20% | 19% | 19% | 11% | 9% | 10% | 15% | 13% | 14% | 12% | 22% | 15% | 13% |
| Net Profit | 169 | 154 | 173 | 184 | 227 | 188 | 191 | 202 | 199 | 193 | 197 | 197 | 258 |
| EPS in Rs | 8.26 | 7.52 | 8.47 | 9.00 | 11.09 | 9.20 | 9.33 | 9.85 | 9.72 | 9.44 | 9.65 | 9.62 | 12.64 |
Last Updated: January 11, 2026, 8:33 am
Below is a detailed analysis of the quarterly data for Narayana Hrudayalaya Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,644.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,507.00 Cr. (Jun 2025) to 1,644.00 Cr., marking an increase of 137.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,243.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,171.00 Cr. (Jun 2025) to 1,243.00 Cr., marking an increase of 72.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 401.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Jun 2025) to 401.00 Cr., marking an increase of 64.00 Cr..
- For OPM %, as of Sep 2025, the value is 24.00%. The value appears strong and on an upward trend. It has increased from 22.00% (Jun 2025) to 24.00%, marking an increase of 2.00%.
- For Other Income, as of Sep 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 24.00 Cr..
- For Interest, as of Sep 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 45.00 Cr. (Jun 2025) to 42.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 87.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 84.00 Cr. (Jun 2025) to 87.00 Cr., marking an increase of 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 296.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Jun 2025) to 296.00 Cr., marking an increase of 64.00 Cr..
- For Tax %, as of Sep 2025, the value is 13.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Jun 2025) to 13.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 258.00 Cr.. The value appears strong and on an upward trend. It has increased from 197.00 Cr. (Jun 2025) to 258.00 Cr., marking an increase of 61.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 12.64. The value appears strong and on an upward trend. It has increased from 9.62 (Jun 2025) to 12.64, marking an increase of 3.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:55 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,095 | 1,364 | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 4,890 | 5,483 | 5,961 |
| Expenses | 989 | 1,236 | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,722 | 4,185 | 4,558 |
| Operating Profit | 106 | 128 | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,168 | 1,298 | 1,403 |
| OPM % | 10% | 9% | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 24% | 24% | 24% |
| Other Income | 39 | 6 | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 73 | 80 | 86 |
| Interest | 31 | 45 | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 163 | 165 |
| Depreciation | 57 | 68 | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 241 | 278 | 324 |
| Profit before tax | 57 | 21 | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 888 | 936 | 1,000 |
| Tax % | 38% | 71% | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | 16% | |
| Net Profit | 29 | -19 | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 791 | 846 |
| EPS in Rs | 974.49 | -0.84 | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.66 | 41.35 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% | 12% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -165.52% | 210.53% | 295.24% | -38.55% | 15.69% | 101.69% | -111.76% | 2542.86% | 77.49% | 30.15% | 0.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 376.04% | 84.71% | -333.79% | 54.24% | 86.01% | -213.46% | 2654.62% | -2465.37% | -47.34% | -30.02% |
Narayana Hrudayalaya Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 14% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 43% |
| 3 Years: | 31% |
| TTM: | -2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 42% |
| 3 Years: | 37% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 25% |
| 3 Years: | 29% |
| Last Year: | 24% |
Last Updated: September 5, 2025, 11:30 am
Balance Sheet
Last Updated: December 10, 2025, 3:08 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.33 | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves | 580 | 568 | 672 | 759 | 831 | 877 | 932 | 916 | 1,284 | 1,927 | 2,679 | 3,422 | 3,855 |
| Borrowings | 333 | 362 | 258 | 217 | 802 | 813 | 952 | 826 | 723 | 884 | 1,627 | 2,428 | 2,340 |
| Other Liabilities | 242 | 241 | 424 | 468 | 692 | 746 | 813 | 833 | 931 | 1,155 | 1,123 | 1,216 | 1,342 |
| Total Liabilities | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 7,742 |
| Fixed Assets | 738 | 913 | 1,054 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,266 | 4,399 |
| CWIP | 20 | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 86 | 135 |
| Investments | 51 | 52 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 | 1,435 |
| Other Assets | 346 | 385 | 402 | 417 | 637 | 729 | 711 | 678 | 964 | 1,323 | 1,624 | 1,835 | 1,773 |
| Total Assets | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 7,742 |
Below is a detailed analysis of the balance sheet data for Narayana Hrudayalaya Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 204.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 204.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,855.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,422.00 Cr. (Mar 2025) to 3,855.00 Cr., marking an increase of 433.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,340.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,428.00 Cr. (Mar 2025) to 2,340.00 Cr., marking a decrease of 88.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,342.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,216.00 Cr. (Mar 2025) to 1,342.00 Cr., marking an increase of 126.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,742.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,271.00 Cr. (Mar 2025) to 7,742.00 Cr., marking an increase of 471.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4,399.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,266.00 Cr. (Mar 2025) to 4,399.00 Cr., marking an increase of 133.00 Cr..
- For CWIP, as of Sep 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 86.00 Cr. (Mar 2025) to 135.00 Cr., marking an increase of 49.00 Cr..
- For Investments, as of Sep 2025, the value is 1,435.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,084.00 Cr. (Mar 2025) to 1,435.00 Cr., marking an increase of 351.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,773.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,835.00 Cr. (Mar 2025) to 1,773.00 Cr., marking a decrease of 62.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,742.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,271.00 Cr. (Mar 2025) to 7,742.00 Cr., marking an increase of 471.00 Cr..
Notably, the Reserves (3,855.00 Cr.) exceed the Borrowings (2,340.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -227.00 | -234.00 | -78.00 | 19.00 | -585.00 | -518.00 | -518.00 | -637.00 | -59.00 | 103.00 | 0.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 45 | 38 | 34 | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 | 37 |
| Inventory Days | 64 | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 44 | 40 |
| Days Payable | 198 | 146 | 152 | 173 | 200 | 177 | 177 | 221 | 180 | 224 | 214 | 185 |
| Cash Conversion Cycle | -90 | -51 | -70 | -98 | -100 | -95 | -111 | -150 | -108 | -158 | -138 | -108 |
| Working Capital Days | 2 | -30 | -12 | -11 | -10 | -10 | -22 | -38 | -16 | -25 | -30 | -17 |
| ROCE % | 8% | 7% | 9% | 14% | 9% | 9% | 14% | 2% | 25% | 32% | 26% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Mirae Asset Large & Midcap Fund | 2,353,594 | 1.02 | 445.3 | 1,618,507 | 2026-01-26 02:50:24 | 45.42% |
| Parag Parikh Flexi Cap Fund | 1,995,914 | 0.28 | 377.63 | N/A | N/A | N/A |
| Axis Small Cap Fund | 1,663,780 | 1.19 | 314.79 | 6,641,167 | 2025-12-08 02:06:47 | -74.95% |
| Mirae Asset Midcap Fund | 1,211,483 | 1.25 | 229.21 | 1,091,916 | 2026-01-26 02:50:24 | 10.95% |
| Nippon India Small Cap Fund | 944,173 | 0.26 | 178.64 | N/A | N/A | N/A |
| Nippon India Pharma Fund | 923,911 | 2.12 | 174.8 | 1,849,571 | 2025-12-08 02:06:47 | -50.05% |
| DSP Small Cap Fund | 721,175 | 0.81 | 136.45 | 1,801,189 | 2025-12-08 02:06:47 | -59.96% |
| Mirae Asset Multicap Fund | 334,725 | 1.38 | 63.33 | N/A | N/A | N/A |
| Mirae Asset Flexi Cap Fund | 251,650 | 1.34 | 47.61 | N/A | N/A | N/A |
| WhiteOak Capital Mid Cap Fund | 230,888 | 0.98 | 43.68 | 207,666 | 2026-01-26 02:50:24 | 11.18% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 38.90 | 38.86 | 29.85 | 16.85 | -0.70 |
| Diluted EPS (Rs.) | 38.90 | 38.86 | 29.85 | 16.85 | -0.70 |
| Cash EPS (Rs.) | 52.30 | 50.49 | 39.97 | 26.14 | 8.62 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 177.34 | 141.18 | 104.35 | 72.88 | 54.84 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 177.34 | 141.18 | 104.35 | 72.88 | 54.84 |
| Revenue From Operations / Share (Rs.) | 268.30 | 245.56 | 221.41 | 181.12 | 126.36 |
| PBDIT / Share (Rs.) | 66.96 | 60.07 | 50.46 | 33.67 | 10.29 |
| PBIT / Share (Rs.) | 53.35 | 48.22 | 40.19 | 24.69 | 1.31 |
| PBT / Share (Rs.) | 45.78 | 43.48 | 36.79 | 21.45 | -2.41 |
| Net Profit / Share (Rs.) | 38.69 | 38.64 | 29.69 | 17.16 | -0.36 |
| NP After MI And SOA / Share (Rs.) | 38.66 | 38.62 | 29.66 | 16.73 | -0.69 |
| PBDIT Margin (%) | 24.95 | 24.46 | 22.79 | 18.59 | 8.14 |
| PBIT Margin (%) | 19.88 | 19.63 | 18.14 | 13.63 | 1.03 |
| PBT Margin (%) | 17.06 | 17.70 | 16.61 | 11.84 | -1.90 |
| Net Profit Margin (%) | 14.41 | 15.73 | 13.40 | 9.47 | -0.28 |
| NP After MI And SOA Margin (%) | 14.41 | 15.72 | 13.39 | 9.23 | -0.55 |
| Return on Networth / Equity (%) | 21.80 | 27.36 | 28.44 | 22.96 | -1.27 |
| Return on Capital Employeed (%) | 17.95 | 21.82 | 25.86 | 21.46 | 1.29 |
| Return On Assets (%) | 10.87 | 14.03 | 14.56 | 10.92 | -0.51 |
| Long Term Debt / Equity (X) | 0.54 | 0.41 | 0.29 | 0.29 | 0.44 |
| Total Debt / Equity (X) | 0.61 | 0.50 | 0.35 | 0.36 | 0.46 |
| Asset Turnover Ratio (%) | 0.85 | 1.03 | 1.00 | 0.95 | 0.66 |
| Current Ratio (X) | 2.14 | 1.75 | 1.31 | 1.17 | 0.94 |
| Quick Ratio (X) | 2.04 | 1.65 | 1.24 | 1.09 | 0.87 |
| Inventory Turnover Ratio (X) | 49.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 10.28 | 6.43 | 3.34 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 7.60 | 4.92 | 2.48 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 89.72 | 93.57 | 96.66 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 92.40 | 95.08 | 97.52 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 9.35 | 12.67 | 14.85 | 10.38 | 2.77 |
| Interest Coverage Ratio (Post Tax) (X) | 6.45 | 9.15 | 9.74 | 6.29 | 0.90 |
| Enterprise Value (Cr.) | 36133.09 | 27191.98 | 16202.98 | 15629.99 | 8692.93 |
| EV / Net Operating Revenue (X) | 6.59 | 5.42 | 3.58 | 4.22 | 3.37 |
| EV / EBITDA (X) | 26.40 | 22.15 | 15.71 | 22.72 | 41.34 |
| MarketCap / Net Operating Revenue (X) | 6.30 | 5.21 | 3.50 | 4.12 | 3.21 |
| Retention Ratios (%) | 89.71 | 93.56 | 96.65 | 0.00 | 0.00 |
| Price / BV (X) | 9.54 | 9.07 | 7.42 | 10.25 | 7.41 |
| Price / Net Operating Revenue (X) | 6.30 | 5.21 | 3.50 | 4.12 | 3.21 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.02 | 0.00 |
After reviewing the key financial ratios for Narayana Hrudayalaya Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 38.90. This value is within the healthy range. It has increased from 38.86 (Mar 24) to 38.90, marking an increase of 0.04.
- For Diluted EPS (Rs.), as of Mar 25, the value is 38.90. This value is within the healthy range. It has increased from 38.86 (Mar 24) to 38.90, marking an increase of 0.04.
- For Cash EPS (Rs.), as of Mar 25, the value is 52.30. This value is within the healthy range. It has increased from 50.49 (Mar 24) to 52.30, marking an increase of 1.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 177.34. It has increased from 141.18 (Mar 24) to 177.34, marking an increase of 36.16.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 177.34. It has increased from 141.18 (Mar 24) to 177.34, marking an increase of 36.16.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 268.30. It has increased from 245.56 (Mar 24) to 268.30, marking an increase of 22.74.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 66.96. This value is within the healthy range. It has increased from 60.07 (Mar 24) to 66.96, marking an increase of 6.89.
- For PBIT / Share (Rs.), as of Mar 25, the value is 53.35. This value is within the healthy range. It has increased from 48.22 (Mar 24) to 53.35, marking an increase of 5.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 45.78. This value is within the healthy range. It has increased from 43.48 (Mar 24) to 45.78, marking an increase of 2.30.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 38.69. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 38.69, marking an increase of 0.05.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 38.66. This value is within the healthy range. It has increased from 38.62 (Mar 24) to 38.66, marking an increase of 0.04.
- For PBDIT Margin (%), as of Mar 25, the value is 24.95. This value is within the healthy range. It has increased from 24.46 (Mar 24) to 24.95, marking an increase of 0.49.
- For PBIT Margin (%), as of Mar 25, the value is 19.88. This value is within the healthy range. It has increased from 19.63 (Mar 24) to 19.88, marking an increase of 0.25.
- For PBT Margin (%), as of Mar 25, the value is 17.06. This value is within the healthy range. It has decreased from 17.70 (Mar 24) to 17.06, marking a decrease of 0.64.
- For Net Profit Margin (%), as of Mar 25, the value is 14.41. This value exceeds the healthy maximum of 10. It has decreased from 15.73 (Mar 24) to 14.41, marking a decrease of 1.32.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 15.72 (Mar 24) to 14.41, marking a decrease of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.80. This value is within the healthy range. It has decreased from 27.36 (Mar 24) to 21.80, marking a decrease of 5.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.95. This value is within the healthy range. It has decreased from 21.82 (Mar 24) to 17.95, marking a decrease of 3.87.
- For Return On Assets (%), as of Mar 25, the value is 10.87. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 10.87, marking a decrease of 3.16.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has increased from 0.41 (Mar 24) to 0.54, marking an increase of 0.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.61. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.61, marking an increase of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 1.03 (Mar 24) to 0.85, marking a decrease of 0.18.
- For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has increased from 1.75 (Mar 24) to 2.14, marking an increase of 0.39.
- For Quick Ratio (X), as of Mar 25, the value is 2.04. This value exceeds the healthy maximum of 2. It has increased from 1.65 (Mar 24) to 2.04, marking an increase of 0.39.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 49.80. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 49.80, marking an increase of 49.80.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.28. This value is below the healthy minimum of 20. It has increased from 6.43 (Mar 24) to 10.28, marking an increase of 3.85.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.60. This value is below the healthy minimum of 20. It has increased from 4.92 (Mar 24) to 7.60, marking an increase of 2.68.
- For Earning Retention Ratio (%), as of Mar 25, the value is 89.72. This value exceeds the healthy maximum of 70. It has decreased from 93.57 (Mar 24) to 89.72, marking a decrease of 3.85.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.40. This value exceeds the healthy maximum of 70. It has decreased from 95.08 (Mar 24) to 92.40, marking a decrease of 2.68.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.35. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 9.35, marking a decrease of 3.32.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 9.15 (Mar 24) to 6.45, marking a decrease of 2.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 36,133.09. It has increased from 27,191.98 (Mar 24) to 36,133.09, marking an increase of 8,941.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.59. This value exceeds the healthy maximum of 3. It has increased from 5.42 (Mar 24) to 6.59, marking an increase of 1.17.
- For EV / EBITDA (X), as of Mar 25, the value is 26.40. This value exceeds the healthy maximum of 15. It has increased from 22.15 (Mar 24) to 26.40, marking an increase of 4.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has increased from 5.21 (Mar 24) to 6.30, marking an increase of 1.09.
- For Retention Ratios (%), as of Mar 25, the value is 89.71. This value exceeds the healthy maximum of 70. It has decreased from 93.56 (Mar 24) to 89.71, marking a decrease of 3.85.
- For Price / BV (X), as of Mar 25, the value is 9.54. This value exceeds the healthy maximum of 3. It has increased from 9.07 (Mar 24) to 9.54, marking an increase of 0.47.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has increased from 5.21 (Mar 24) to 6.30, marking an increase of 1.09.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Narayana Hrudayalaya Ltd:
- Net Profit Margin: 14.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.95% (Industry Average ROCE: 10.6%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.8% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.45
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.04
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 45 (Industry average Stock P/E: 114.45)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.61
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.41%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | No.258/A, Bommasandra Industrial Area, Bengaluru Karnataka 560099 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Devi Prasad Shetty | Chairman & Wholetime Director |
| Mr. Viren Prasad Shetty | Executive Vice Chairman |
| Dr. Emmanuel Rupert | Managing Director & Group CEO |
| Dr. Kiran Mazumdar Shaw | Non Executive Director |
| Dr. Anesh Shetty | Non Executive Director |
| Ms. Nivruti Rai | Independent Director |
| Ms. Terri Smith Bresenham | Independent Director |
| Mr. Shankar Arunachalam | Independent Director |
| Dr. Nachiket Mor | Independent Director |
| Mr. Naveen Tewari | Independent Director |
FAQ
What is the intrinsic value of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd's intrinsic value (as of 15 February 2026) is ₹2082.81 which is 14.44% higher the current market price of ₹1,820.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹37,190 Cr. market cap, FY2025-2026 high/low of ₹2,372/1,296, reserves of ₹3,855 Cr, and liabilities of ₹7,742 Cr.
What is the Market Cap of Narayana Hrudayalaya Ltd?
The Market Cap of Narayana Hrudayalaya Ltd is 37,190 Cr..
What is the current Stock Price of Narayana Hrudayalaya Ltd as on 15 February 2026?
The current stock price of Narayana Hrudayalaya Ltd as on 15 February 2026 is ₹1,820.
What is the High / Low of Narayana Hrudayalaya Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Narayana Hrudayalaya Ltd stocks is ₹2,372/1,296.
What is the Stock P/E of Narayana Hrudayalaya Ltd?
The Stock P/E of Narayana Hrudayalaya Ltd is 45.0.
What is the Book Value of Narayana Hrudayalaya Ltd?
The Book Value of Narayana Hrudayalaya Ltd is 199.
What is the Dividend Yield of Narayana Hrudayalaya Ltd?
The Dividend Yield of Narayana Hrudayalaya Ltd is 0.25 %.
What is the ROCE of Narayana Hrudayalaya Ltd?
The ROCE of Narayana Hrudayalaya Ltd is 20.8 %.
What is the ROE of Narayana Hrudayalaya Ltd?
The ROE of Narayana Hrudayalaya Ltd is 24.2 %.
What is the Face Value of Narayana Hrudayalaya Ltd?
The Face Value of Narayana Hrudayalaya Ltd is 10.0.